Concepedia

Jason C. Rech

JC

Statistics

Publications

17

Citations

853

H-Index

16

Active since

2002

Affiliations

Janssen (United States)(Current)

University of Pittsburgh

Janssen (Belgium)

Jason C. Rech is an author at Janssen (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

ORCID

Publications per year

2002–2021

17

Publications

17

Forced swimming evokes a biphasic response in CREB phosphorylation in extrahypothalamic limbic and neocortical brain structures in the rat

Alicia Bilang‐Bleuel, Jason C. Rech, Sonja De Carli et al. · European Journal of Neuroscience · 2002 · 130 citations

, , +14

Synthesis of Potent Bicyclic Bisarylimidazole c-Jun N-Terminal Kinase Inhibitors by Catalytic C−H Bond Activation

Jason C. Rech, Michihisa Yato, Derek R. Duckett et al. · Journal of the American Chemical Society · 2006 · 102 citations · Full text

, , +13

Total Synthesis and Biological Evaluation of Pederin, Psymberin, and Highly Potent Analogs

Shuangyi Wan, Fanghui Wu, Jason C. Rech et al. · Journal of the American Chemical Society · 2011 · 90 citations

, , +11

Catalytic Enantioselective Addition of Arylboronic Acids to <i>N</i>-Boc Imines Generated in Situ

Hiroshi Nakagawa, Jason C. Rech, Robert W. Sindelar et al. · Organic Letters · 2007 · 79 citations

, , +5

P2X7 receptor antagonism reduces the severity of spontaneous seizures in a chronic model of temporal lobe epilepsy

Halima Amhaoul, Idrish Ali, Marco Mola et al. · Neuropharmacology · 2016 · 68 citations

, , +7

1–5 of 17